Clinical evaluation of the Digene Hybrid Capture II test and the COBAS AMPLICOR Monitor test for determination of hepatitis B virus DNA levels

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3513-3517

  Yuan, He Jun ^a,b   Yuen, Man Fung ^a   Wong, Danny Ka Ho ^a   Sum, Simon Siu Man ^a   Lai, Ching Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; COBAS AMPLICOR MONITOR TEST; DIAGNOSTIC TEST; DIGENE HYBRID CAPTURE TEST; FEMALE; HEPATITIS B VIRUS; HUMAN; LABORATORY TEST; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; VIREMIA; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION;

DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 3843113416     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3513-3517.2004     Document Type: Article

References (11)

1. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
2. Ho, S. K., T. M. Chan, I. K. Cheng, and K. N. Lai. 1999. Comparison of the second-generation Digene hybrid capture assay with the branched-DNA assay for measurement of hepatitis B virus DNA in serum. J. Clin. Microbiol. 37:2461-2465.
3. Niesters, H. G., M. Krajden, L. Cork, M. de Medina, M. Hill, E. Fries, and A. D. Osterhaus. 2000. A multicenter study evaluation of the Digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J. Clin. Microbiol. 38:2150-2155.
4. Noborg, U., A. Gusdal, E. K. Pisa, A. Hedrum, and M. Lindh. 1999. Automated quantitative analysis of hepatitis B virus DNA by using the COBAS AMPLICOR HBV Monitor test. J. Clin. Microbiol. 37:2793-2797.
5. Pawlotsky, J. M. 2002. Molecular diagnosis of viral hepatitis. Gastroenterology 122:1554-1568.
6. Pawlotsky, J. M., A. Bastie, C. Hezode, I. Lonjon, F. Darthuy, J. Remire, and D. Dhumeaux. 2000. Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J. Virol. Methods 85:11-21.
7. Pawlotsky, J. M., A. Bastie, I. Lonjon, J. Remire, F. Darthuy, C. J. Soussy, and D. Dhumeaux. 1997. What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J. Virol. Methods 65:245-253.
8. Poljak, M., I. J. Marin, K. Seme, V. Brinovec, M. Maticic, J. Meglic-Volkar, G. Lesnicar, and A. Vince. 2001. Second-generation Hybrid capture test and Amplicor monitor test generate highly correlated hepatitis B virus DNA levels. J. Virol. Methods 97:165-169.
9. Puchhammer-Stockl, E., C. W. Mandl, J. Kletzmayr, H. Holzmann, A. Hofmann, S. W. Aberle, F. X. Heinz, B. Watschinger, and H. Hofmann. 2000. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J. Infect. Dis. 181:2063-2066.
10. Yuen, M. F., E. Sablon, C. K. Hui, H. J. Yuan, H. Decraemer, and C. L. Lai. 2001. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 34:785-791.
11. Yuen, M. F., H. J. Yuan, C. K. Hui, D. K. Wong, W. M. Wong, A. O. Chan, B. C. Wong, and C. L. Lai. 2003. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 52:416-441.